LabGenius combines artificial intelligence, robotic automation and synthetic biology to evolve next-generation protein therapeutics.

LabGenius develops therapeutics of high value for diseases of unmet need. The company deploys machine intelligence to model the relationship between DNA sequence and protein function, while improving the predictive accuracy of these models through experimental lab data generated through its smart robotic platform.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2019

• Founders

  • James Field

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • We've welcomed Caroline to the @labgeni_us team as VP People. With a wealth of experience in venture-backed deep… https://t.co/VUFeJEokoU@labgeni_us - 21h
  • 🚀 We're excited to contribute to this year’s @stateofaireport by @nathanbenaich and @soundboy. 🤖 The report captur… https://t.co/9LsbzNc9TN@labgeni_us - 04:50 PM Oct 12th
  • "Everybody who has a disease is on a clock, and every minute of every day that clock is ticking..." which is why w… https://t.co/MqzKdzR6n1@labgeni_us - 01:46 PM Oct 1st